After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Collegium Pharmaceutical Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Collegium Pharmaceutical Inc is $1.56B. A total of 0.69 million shares were traded on the day, compared to an average of 463.40K shares.
In the most recent transaction, RITA BALICE-GORDON bought 3,650 shares of COLL for 47.03 per share on Dec 05 ’25. In a previous transaction on Dec 08 ’25, Dreyer Scott sold 17,600 shares at 48.17 per share. COLL shares that EVP & Chief Commercial Officer owns now total 103,613.
Among the insiders who sold shares, Balice-Gordon Rita J. disposed of 3,650 shares on Dec 05 ’25 at a per-share price of $47.03. This resulted in the Director holding 52,629 shares of COLL after the transaction. In another insider transaction, Dreyer Scott bought 17,600 shares at $48.17 per share on Dec 08 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, COLL has a high of $49.49 and a low of $23.23.
As of this writing, COLL has an earnings estimate of $2.15 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $2.26 per share and a lower estimate of $1.93. The company reported an EPS of $1.77 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. COLL’s latest balance sheet shows that the firm has $186.43M in Cash & Short Term Investments as of fiscal 2021. There were $258.75M in debt and $279.57M in liabilities at the time. Its Book Value Per Share was $8.70, while its Total Shareholder’s Equity was $202.93M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for COLL is Buy with a score of 4.57.
